Cited by 803Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 173 of the 176 references it cites were found in a registry or an index.

Parkinson’s disease: genetics and pathogenesis

Shulman, Joshua M., De Jager, Philip L., Feany, Mel B.·2011·Annual Review of Pathology: Mechanisms of Disease

DOI 10.1146/annurev-pathol-011110-130242

Open this paper in CoChat — free account

Abstract

Recent investigation into the mechanisms of Parkinson's disease (PD) has generated remarkable insight while simultaneously challenging traditional conceptual frameworks. Although the disease remains defined clinically by its cardinal motor manifestations and pathologically by midbrain dopaminergic cell loss in association with Lewy bodies, it is now recognized that PD has substantially more widespread impact, causing a host of nonmotor symptoms and associated pathology in multiple regions throughout the nervous system. Further, the discovery and validation of PD-susceptibility genes contradict the historical view that environmental factors predominate, and blur distinctions between familial and sporadic disease. Genetic advances have also promoted the development of improved animal models, highlighted responsible molecular pathways, and revealed mechanistic overlap with other neurodegenerative disorders. In this review, we synthesize emerging lessons on PD pathogenesis from clinical, pathological, and genetic studies toward a unified concept of the disorder that may accelerate the design and testing of the next generation of PD therapies.

Integrity signals

Registry

Crossref · 10.1146/annurev-pathol-011110-130242

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
α-Synuclein in Lewy bodies
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Parkinson's Disease
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836

Show all 176 references

Research works printed but not linked: 4

Parkinson J, 1817, An Essay on the Shaking Palsy
Priyadarshi A, 2000, Neurotoxicology, 21, 435
Gilks W, 2005, Lancet, 365, 415
Nichols WC, 2005, Lancet, 365, 410

Sorted by citations

Inflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340
Liquid-Liquid Phase Separation in Biology
Hyman, A. A., Weber, C. A., & Jülicher, F. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013325 · Cited by 3,155
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112
Chemical Biology of H 2 S Signaling through Persulfidation
Filipović, M. R., Živanović, J., Álvarez, B., & Banerjee, R. V. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00205 · Cited by 1,059
The Adverse Effects of Air Pollution on the Nervous System
Genç, Ş., Zadeoğluları, Z., Fuss, S. H., & Genç, K. (2012) · Journal of Toxicology · doi:10.1155/2012/782462 · Cited by 756
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
Romano, S., Savva, G. M., Bedarf, J. R., Charles, I. G., Hildebrand, F., & Narbad, A. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-021-00156-z · Cited by 707
Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment
Greene, A. W., Grenier, K., Aguileta, M. A., Muise, S., Farazifard, R., Haque, M. E., McBride, H. M., Park, D. S., & Fon, E. A. (2012) · The EMBO Reports · doi:10.1038/embor.2012.14 · Cited by 711
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 677
Curcumin and its Derivatives: Their Application in Neuropharmacology and Neuroscience in the 21st Century
Lee, W., Loo, C., Bebawy, M., Luk, F., Mason, R. S., & Rohanizadeh, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040002 · Cited by 552
Axon degeneration in Parkinson's disease
Burke, R. E., & O’Malley, K. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.011 · Cited by 514
Microbiome–microglia connections via the gut–brain axis
Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K., & Mazmanian, S. K. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180794 · Cited by 471
MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function
Miñones-Moyano, E., Porta, S., Escaramís, G., Rabionet, R., Iraola‐Guzmán, S., Kagerbauer, B., Espinosa‐Parrilla, Y., Ferrer, I., Estivill, X., & Martí, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr210 · Cited by 491
Basal Ganglia Disorders Associated with Imbalances in the Striatal Striosome and Matrix Compartments
Crittenden, J. R., & Graybiel, A. M. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00059 · Cited by 470
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 477
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease
Wang, S., Yuan, Y., Chen, N., & Wang, H. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.019 · Cited by 452
Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—A mechanistic approach
Baltazar, M. T., Dinis‐Oliveira, R. J., Bastos, M. D. L., Tsatsakis, A. M., Duarte, J. A., & Carvalho, F. D. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.039 · Cited by 410
The Microbiome and Human Biology
Knight, R., Callewaert, C., Marotz, C., Hyde, E. R., Debelius, J. W., McDonald, D., & Sogin, M. L. (2017) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083115-022438 · Cited by 373
Mitochondrial Quality Control Mediated by PINK1 and Parkin: Links to ParkinsonismPreprint
Narendra, D. P., Walker, J. E., & Youle, R. J. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011338 · Cited by 360
Parkin overexpression during aging reduces proteotoxicity, alters mitochondrial dynamics, and extends lifespan
Rana, A., Rera, M., & Walker, D. W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216197110 · Cited by 335
Phase Separation: Linking Cellular Compartmentalization to Disease
Aguzzi, A., & Altmeyer, M. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.03.004 · Cited by 343
An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene–environment interactions
Johnson, M., & Bobrovskaya, L. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.12.002 · Cited by 344
Alpha‐Synuclein as a Biomarker for Parkinson's Disease
Atik, A., Stewart, T., & Zhang, J. (2016) · Brain Pathology · doi:10.1111/bpa.12370 · Cited by 311
Focus on the Role of NLRP3 Inflammasome in Diseases
Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., & Paola, R. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124223 · Cited by 301
The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review
Fontana, B. D., Mezzomo, N. J., Kalueff, A. V., & Rosemberg, D. B. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.004 · Cited by 289
The role of the LRRK2 gene in Parkinsonism
Li, J.-Q., Tan, L., & Yu, J.-T. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-47 · Cited by 249
Is Pesticide Use Related to Parkinson Disease? Some Clues to Heterogeneity in Study Results
van der Mark, M., Brouwer, M., Kromhout, H., Nijssen, P. C. G., Huss, A., & Vermeulen, R. C. H. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1103881 · Cited by 237
Parkinson's Disease Genetics and Pathophysiology
Vázquez-Vélez, G. E., & Zoghbi, H. Y. (2021) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-100720-034518 · Cited by 244
Inflammasomes as therapeutic targets in human diseases
Li, Y., Huang, H., Liu, B., Zhang, Y. L., Pan, X., Yu, X., Shen, Z., & Song, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00650-z · Cited by 238
α-synuclein Induces Mitochondrial Dysfunction through Spectrin and the Actin Cytoskeleton
Ordonez, D. G., Lee, M. K., & Feany, M. B. (2018) · Neuron · doi:10.1016/j.neuron.2017.11.036 · Cited by 227
Self-citation
The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s Diseases
Zhang, J., Li, X., & Li, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00381 · Cited by 225
Nigral pathology and parkinsonian signs in elders without Parkinson disease
Buchman, A. S., Shulman, J. M., Nag, S., Leurgans, S. E., Arnold, S. E., Morris, M. C., Schneider, J. A., & Bennett, D. A. (2011) · Annals of Neurology · doi:10.1002/ana.22588 · Cited by 220
Self-citation
The role of free radicals in the aging brain and Parkinson’s Disease: Convergence and parallelism
Kumar, H., Lim, H.-W., More, S. V., Kim, B.-W., Koppula, S., Kim, I. S., & Choi, D.-K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810478 · Cited by 212
Mitochondrial reactive oxygen species and inflammation: Molecular mechanisms, diseases and promising therapies
Rimessi, A., Previati, M., Nigro, F., Wieckowski, M. R., & Pinton, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.06.015 · Cited by 216
Persulfidation (S-sulfhydration) and H2S
Filipović, M. R. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-18144-8_2 · Cited by 210
Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease
Alvarez‐Erviti, L., Seow, Y., Schapira, A. H. V., Rodríguez-Oroz, M. C., Obeso, J. A., & Cooper, J. A. D. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.73 · Cited by 208
Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease
Gaki, G. S., & Papavassiliou, A. G. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8294-x · Cited by 206
Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function
Gladding, C. M., & Raymond, L. A. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.05.001 · Cited by 214
Glycosaminoglycan‐Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials
Freudenberg, U., Liang, Y., Kiick, K. L., & Werner, C. (2016) · Advanced Materials · doi:10.1002/adma.201601908 · Cited by 200
Modelling of Parkinson's disease in mice
Chesselet, M., & Richter, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70227-7 · Cited by 190
Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models
Cannon, J. R., & Greenamyre, J. T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.025 · Cited by 194
The role of Ca2+ signaling in Parkinson's disease
Zaichick, S., McGrath, K. M., & Caraveo, G. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028738 · Cited by 191
Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?
Fan, C., Holland, C. V., Loxton, K., & Barghouth, U. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00106-14 · Cited by 185
Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
Devoto, V. M. P., & Falzone, T. L. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.026294 · Cited by 184
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Tran, J., Anastacio, H. T. D., & Bardy, C. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-0110-8 · Cited by 190
α-synuclein aggregation and its modulation
Ghosh, D., Mehra, S., Sahay, S., Singh, P. K., & Maji, S. K. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.021 · Cited by 193
The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability
Hallacli, E., Kayatekin, C., Nazeen, S., Wang, X. H., Sheinkopf, Z. R., Sathyakumar, S., Sarkar, S., Jiang, X. J., Dong, X., Maio, R. D., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.008 · Cited by 171
Self-citation
Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease
Ding, H., Huang, Z., Chen, M., Wang, C., Chen, X., Chen, J., & Zhang, J. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.11.014 · Cited by 172
A Single Dopamine Pathway Underlies Progressive Locomotor Deficits in a Drosophila Model of Parkinson Disease
Riemensperger, T. D., Issa, A.-R., Pech, U., Coulom, H., Nguyễn, M.-V., Cassar, M., Jacquet, M., Fiala, A., & Birman, S. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.032 · Cited by 166
Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics
Gandhi, J., Antonelli, A. C., Afridi, A., Vatsia, S. K., Joshi, G. S., Romanov, V., Murray, I. V. J., & Khan, S. A. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0035 · Cited by 171
miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1)
Kim, J., Fiesel, F. C., Belmonte, K. C., Hudec, R., Wang, W.-X., Kim, C., Nelson, P. T., Springer, W., & Kim, J. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0121-4 · Cited by 163
“To date, mutations in several genes, such as SNCA (α-synuclein), Leucine-rich repeat kinase 2 (LRRK2), DJ-1, PARK2 (PARKIN), and PTEN-induced putative kinase 1 (PINK1) [1], have been shown to cause familial early-onset PD, accounting for 5–10 % of all cases [2].”
Background
Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice
Antunes, M. S., Goes, A. T. R., Boeira, S. P., Prigol, M., & Jessé, C. R. (2014) · Nutrition · doi:10.1016/j.nut.2014.03.024 · Cited by 165
Rosmarinic acid suppresses Alzheimer’s disease development by reducing amyloid β aggregation by increasing monoamine secretion
Hase, T., Shishido, S., Yamamoto, S., Yamashita, R., Nukima, H., Taira, S., Toyoda, T., Abe, K., Hamaguchi, T., Ono, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45168-1 · Cited by 162
Nigral Iron Elevation Is an Invariable Feature of Parkinson’s Disease and Is a Sufficient Cause of Neurodegeneration
Ayton, S., & Lei, P. (2014) · BioMed Research International · doi:10.1155/2014/581256 · Cited by 163
MicroRNAs in Parkinson's disease
Harraz, M. M., Dawson, T. M., & Dawson, V. L. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.01.005 · Cited by 161
Gene-by-environment interactions in Alzheimer’s disease and Parkinson’s disease
Dunn, A. R., O’Connell, K. M. S., & Kaczorowski, C. C. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.06.018 · Cited by 160
Animal models of the non-motor features of Parkinson's disease
McDowell, K. A., & Chesselet, M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.040 · Cited by 158
Motor Learning Deficits in Parkinson's Disease (PD) and Their Effect on Training Response in Gait and Balance: A Narrative Review
Olson, M. C., Lockhart, T. E., & LIEBERMAN, A. N. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00062 · Cited by 155
Intranasal Administration of Extracellular Vesicles Derived from Human Teeth Stem Cells Improves Motor Symptoms and Normalizes Tyrosine Hydroxylase Expression in the Substantia Nigra and Striatum of the 6-Hydroxydopamine-Treated Rats
Narbute, K., Piļipenko, V., Pupure, J., Dzirkale, Z., Jonavičė, U., Tunaitis, V., Kriaučiūnaitė, K., Jarmalavičiūtė, A., Jansone, B., Kluša, V., et al. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0162 · Cited by 150
Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies
Ma, L., Azad, M. G., Dharmasivam, M., Richardson, V., Quinn, R. J., Feng, Y., Pountney, D. L., Tonissen, K. F., Mellick, G. D., Yanatori, I., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101896 · Cited by 151
Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: Interplay between PI3K/Akt/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221
Salama, R. M., Abdel‐Latif, G. A., Abbas, S. S., Magdoub, H. M. E., & Schaalan, M. F. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107900 · Cited by 149
Bile acids: a communication channel in the gut-brain axis
Monteiro-Cardoso, V. F., Corlianò, M., & Singaraja, R. R. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08625-z · Cited by 145
A Mitocentric View of Parkinson's Disease
Haelterman, N. A. T., Yoon, W. H., Sandoval, H., Jaiswal, M., Shulman, J. M., & Bellen, H. J. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014317 · Cited by 141
Self-citation
DICE, an efficient system for iterative genomic editing in human pluripotent stem cells
Zhu, F., Gamboa, M., Farruggio, A. P., Hippenmeyer, S., Tasic, B., Schüle, B., Chen-Tsai, Y., & Calos, M. P. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1290 · Cited by 143
RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2
Zu, T., Cleary, J. D., Liu, Y., Báñez-Coronel, M., Bubenik, J. L., Ayhan, F., Ashizawa, T., Xia, G., Clark, H. B., Yachnis, A. T., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.08.039 · Cited by 147
Eye Movements in Parkinson’s Disease and Inherited Parkinsonian Syndromes
Pretegiani, E., & Optican, L. M. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00592 · Cited by 137
Dopamine midbrain neurons in health and Parkinson’s disease: Emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels
Dragicevic, E., Schiemann, J. M., & Liss, B. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.037 · Cited by 141
Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson’s disease
Pilsl, A., & Winklhofer, K. F. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0902-3 · Cited by 131
Neurotrophic Natural Products: Chemistry and Biology
Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302268 · Cited by 124
Recent advances in quantitative neuroproteomics
Craft, G. E., Chen, A., & Nairn, A. C. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.008 · Cited by 127
In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons
Chung, C. Y., Khurana, V., Yi, S. S., Sahni, N., Loh, K. H., Auluck, P. K., Baru, V., Udeshi, N. D., Freyzon, Y., Carr, S. A., et al. (2017) · Cell Systems · doi:10.1016/j.cels.2017.01.002 · Cited by 124
Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules
Harilal, S., Jose, J., Parambi, D. G. T., Kumar, R., Unnikrishnan, M. K., Uddin, M. S., Mathew, G. E., Pratap, R., Marathakam, A., & Mathew, B. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.018 · Cited by 127
Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons
Dragicevic, E., Pötschke, C., Duda, J., Schlaudraff, F., Lammel, S., Schiemann, J. M., Fauler, M., Hetzel, A., Watanabe, M., Luján, R., et al. (2014) · Brain · doi:10.1093/brain/awu131 · Cited by 128
Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways
Khurana, V., Peng, J., Chung, C. Y., Auluck, P. K., Fanning, S., Tardiff, D. F., Bartels, T., Koeva, M., Eichhorn, S. W., Benyamini, H., et al. (2017) · Cell Systems · doi:10.1016/j.cels.2016.12.011 · Cited by 121
Ultra-High 7T MRI of Structural Age-Related Changes of the Subthalamic Nucleus
Keuken, M. C., Bazin, P., Andreas Schäfer, A., Neumann, J., Turner, R., & Forstmann, B. U. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3241-12.2013 · Cited by 117
The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review
Wen, K., Milić, J., El‐Khodor, B. F., Dhana, K., Nano, J., Pulido, T., Kraja, B., Začiragić, A., Bramer, W. M., Troup, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167201 · Cited by 130
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy
Modesti, L., Danese, A., Vitto, V. A. M., Ramaccini, D., Aguiari, G., Gafà, R., Lanza, G., Giorgi, C., & Pinton, P. (2021) · Cells · doi:10.3390/cells10061317 · Cited by 123
Recent Advances in α-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson’s Disease
Guerrero, E., Vasudevaraju, P., Hegde, M. L., Britton, G. B., & Rao, K. S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8328-z · Cited by 121
Molecular Chaperone Dysfunction in Neurodegenerative Diseases and Effects of Curcumin
Maiti, P., Manna, J., Veleri, S., & Frautschy, S. A. (2014) · BioMed Research International · doi:10.1155/2014/495091 · Cited by 121
Advances in pig models of human diseases
Hou, N., Du, X., & Wu, S. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12223 · Cited by 127
Serum uric acid levels in patients with Parkinson’s disease: A meta-analysis
Wen, M., Zhou, B., Chen, Y.-H., Ma, Z.-L., Gou, Y., Zhang, C., Yu, W., & Jiao, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173731 · Cited by 120
Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing
Jansen, I. E., Ye, H., Heetveld, S., Lechler, M. C., Michels, H., Seinstra, R. I., Lubbe, S. J., Drouet, V., Lesage, S., Majounie, E., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1147-9 · Cited by 115
Self-citation
Multifactorial theory applied to the neurotoxicity of paraquat and paraquat-induced mechanisms of developing Parkinson's disease
Zhang, X., Thompson, M., & Xu, Y.-H. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.161 · Cited by 116
Advances in microstructural diffusion neuroimaging for psychiatric disorders
Pasternak, O., Kelly, S., Sydnor, V. J., & Shenton, M. E. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.04.051 · Cited by 116
The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells
Pan, T., Zhu, J. X., Hwu, W., & Jankovic, J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045183 · Cited by 115
A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its Derivatives
Abdoulaye, I. A., & Guo, Y. J. (2016) · BioMed Research International · doi:10.1155/2016/5012341 · Cited by 116
mTOR Signaling in Parkinson’s Disease
Lan, A., Chen, J., Zhao, Y., Chai, Z., & Hu, Y. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8417-7 · Cited by 117
Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease
Ai, S., Xu, Q., Hu, Y., Song, C., Guo, J., Shen, L. H., Wang, C., Yu, R.-L., Yan, X., & Tang, B. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.11.033 · Cited by 113
The Proteasome Inhibition Model of Parkinson’s Disease
Bentea, E., Verbruggen, L., & Massie, A. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160921 · Cited by 116
Serum miR‐221 serves as a biomarker for Parkinson's disease
Ma, W., Li, Y., Wang, C., Xu, F., Wang, M., & Liu, Y. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3224 · Cited by 109
What Can We Learn About Human Disease from the Nematode C. elegans?
Apfeld, J., & Alper, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7471-9_4 · Cited by 116
Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis
Ren, Z., Wang, C., Wang, T., Ding, H., Zhou, M., Yang, N., Liu, Y., & Chan, P. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0077-8 · Cited by 109
Mast Cells in Neurodegenerative Disease
Jones, M. K., Nair, A. A., & Gupta, M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00171 · Cited by 107
Modeling human neurodegenerative diseases in transgenic systems
Sosa, M. A. G., Gasperi, R. D., & Elder, G. A. (2011) · Human Genetics · doi:10.1007/s00439-011-1119-1 · Cited by 114
Cellular models to investigate biochemical pathways in Parkinson’s disease
Alberio, T., Lopiano, L., & Fasano, M. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08516.x · Cited by 108
Carbon nanotubes and graphene as emerging candidates in neuroregeneration and neurodrug delivery
Jaganathan, S. K., John, A., Vellayappan, M. V., Balaji, A., Mohandas, H., & Subramanian, A. P. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s83777 · Cited by 109
Animal Models of Parkinson's Disease: A Gateway to Therapeutics?
Le, W., Sayana, P., & Jankovic, J. J. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0234-1 · Cited by 114
Role of Plant-Derived Flavonoids and Their Mechanism in Attenuation of Alzheimer’s and Parkinson’s Diseases: An Update of Recent Data
Hussain, G., Zhang, L., Rasul, A., Anwar, H., Sohail, M. U., Razzaq, A., Aziz, N., Shabbir, A., Ali, M. Z., & Sun, T. (2018) · Molecules · doi:10.3390/molecules23040814 · Cited by 110
Drosophila as a Model to Study Mitochondrial Dysfunction in Parkinson's DiseasePreprint
Guo, M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009944 · Cited by 111
The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease
Ren, H., Zhai, W., Lu, X., & Wang, G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.691881 · Cited by 106
C dk5‐ D ependent A ctivation of N euronal I nflammasomes in P arkinson's D isease
Zhang, P., Shao, X., Qi, G., Chen, Q., Bu, L.-L., Chen, L., Shi, J., Ming, J., & Tian, B. (2016) · Movement Disorders · doi:10.1002/mds.26488 · Cited by 102

Authors: Shulman, J. M., De Jager, P. L., & Feany, M. B.
Affiliations: Broad Institute (US)
Departments of Neurology, Boston, Massachusetts 02115;
Departments of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115;
ORCID: Shulman, Joshua M.
Venue: Annual Review of Pathology: Mechanisms of Disease
Publisher: Annual Reviews
Published: 2011-02-28
Volume: 6
Issue: 1
Pages: 193-222
ISSN: 1553-4006 (ISSN-L)
1553-4014
DOI: 10.1146/annurev-pathol-011110-130242
OpenAlex: W2129917779
Cited by: 801
References: 176
Citations by year: 2026: 10 · 2025: 21 · 2024: 42 · 2023: 34 · 2022: 64 · 2021: 64 · 2020: 46 · 2019: 59 · 2018: 54 · 2017: 59 · 2016: 74 · 2015: 64 · 2014: 56 · 2013: 65 · 2012: 52
FWCI: 8.22
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Pathology Mechanisms of Disease (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Parkinson's disease, susceptibility genes, pathogenesis, dopaminergic neuron loss, Lewy bodies, non-motor symptoms, animal models, neurodegeneration, molecular pathways
MeSH terms: Animals, Humans, Parkinson Disease, Lewy Bodies, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Parkinson’s disease: genetics and pathogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks